다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Hoth Therapeutics Inc (HOTH)
Hoth Therapeutics Inc (HOTH) 뉴스

HOTH

Hoth Therapeutics (HOTH)

Hoth Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HOTH

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/05/01	21:00	PR Newswire (US)	Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/03/28	03:00	PR Newswire (US)	Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/03/27	21:27	PR Newswire (US)	Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/03/19	21:21	PR Newswire (US)	Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/02/29	22:38	PR Newswire (US)	Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/02/26	22:11	PR Newswire (US)	Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/02/14	01:45	PR Newswire (US)	Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/01/18	22:20	PR Newswire (US)	Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/01/10	05:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/01/09	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/01/09	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/01/09	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2024/01/09	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/12/27	22:21	PR Newswire (US)	Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/12/05	22:33	PR Newswire (US)	Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/11/14	22:37	PR Newswire (US)	Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/11/14	06:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/11/10	22:00	PR Newswire (US)	Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/10/05	23:03	PR Newswire (US)	Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/10/05	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/10/02	21:33	PR Newswire (US)	FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/09/16	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/09/16	03:38	PR Newswire (US)	Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/09/15	06:24	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/09/14	02:43	PR Newswire (US)	Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/09/13	21:16	PR Newswire (US)	Hoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/09/11	23:04	PR Newswire (US)	Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/09/06	21:12	PR Newswire (US)	Hoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa	NASDAQ:HOTH	Hoth Therapeutics Inc
2023/08/22	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc

검색 관련기사 보기:NASDAQ:HOTH

1 2 3 4 5 6 7 8 9 10 다음 >>

Graniteshares 3x Short P...

Societe Generale Effekten

Tellor Tributes

Tarsus Pharmaceuticals

Veolia Env Tf 1,59% Ge28...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관